Concepedia

Thomas Gobbetti

TG

21

Publications

1.8K

Citations

19

H-Index

2008

Active since

Affiliations

Queen Mary University of London(Current)

William Harvey Research Institute

Université Toulouse III - Paul Sabatier

Inserm

University of Parma

Thomas Gobbetti is an author at Queen Mary University of London specializing in medicine, immunology, and inflammation.

ORCID

Top concepts

Publications per year

2008–2022

21

Publications

21

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 411 citations · Full text

Ligand-specific conformational change of the G-protein–coupled receptor ALX/FPR2 determines proresolving functional responses

Sadani N. Cooray, Thomas Gobbetti, Trinidad Montero‐Melendez et al. · Proceedings of the National Academy of Sciences · 2013 · 292 citations · Full text

Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation

Simon McArthur, Gaëtan Juban, Thomas Gobbetti et al. · Journal of Clinical Investigation · 2020 · 177 citations · Full text

, , +28

Protectin D1 <sub>n-3 DPA</sub> and resolvin D5 <sub>n-3 DPA</sub> are effectors of intestinal protection

Thomas Gobbetti, Jesmond Dalli, Romain A. Colas et al. · Proceedings of the National Academy of Sciences · 2017 · 157 citations · Full text

Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis

Thomas Gobbetti, Sina M. Coldewey, Jianmin Chen et al. · Proceedings of the National Academy of Sciences · 2014 · 116 citations

Rows per page

1–5 of 21